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ABSTRACT In the vertebrate neuroepithelium, the decision to differentiate is made by neu-
ral precursors soon after mitosis, when they are apically located. This process is controlled by 
lateral inhibitory signals triggered by the Delta/Notch pathway. During mitosis, the capacity 
of neural precursors to express the neurogenic genes Dll1 and Notch1 is maximal due to 
mRNA stabilization, but the mechanism controlling this process remains unknown. Here we 
show that Elav-like (Elavl1)/HuR becomes enriched in the cytoplasm of neuroepithelial cells 
undergoing mitosis and that this ribonucleoprotein interacts with the 3′ untranslated region 
(UTR) of Dll1 mRNA. This interaction is functionally relevant because RNAi against Elavl1 re-
duces the stability of Dll1–3′UTR-containing transcripts in mitosis-arrested neuroepithelial 
cells, and Elavl1 null-mutant heterozygous mice show decreased Dll1 expression in the devel-
oping brain in vivo. We also show that RNAi against Elavl1 diminishes the capacity of brain 
precursors to trigger lateral inhibitory signals to their neighbors, an observation consistent 
with the increase in the rate of neurogenesis which can be detected in vivo in the developing 
retina of Elavl1 heterozygous mice. We conclude that Elavl1/HuR facilitates the exposure of 
vertebrate neuronal precursors to apically located Delta/Notch signals.
INTRODUCTION
Most vertebrate neurons arise from a pseudostratified neuroepithe-
lium constituted by neural precursors the nuclei of which occupy a 
basal position during S-phase while they displace to the apical re-
gion during mitosis (M) (Sauer, 1935; Frade, 2002). The decision of 
coming out from the cell cycle and becoming a neuron is made by 
neural precursors during or soon after their last M, when they are 
apically located and the capacity to express determination proneu-
ral genes, known to initiate a cascade of events leading to neuronal 
differentiation (Bertrand et al., 2002), is maximal (Murciano et al., 
2002; Cisneros et al., 2008). Whether or not a neural precursor 
comes out from the cell cycle and differentiates is tightly regulated 
by intercellular lateral inhibitory signals involving the Delta ligand 
and its Notch receptor (Louvi and Artavanis-Tsakonas, 2006). Notch 
activation by Delta can repress the expression of determination 
proneural genes, thereby preventing neuronal differentiation. More-
over, such activation prevents the expression of Delta itself. There-
fore the Delta/Notch signaling pathway gives rise to a feedback 
loop that can amplify differences between adjacent cells, because 
the receipt of inhibition (i.e., activation of Notch) diminishes the abil-
ity to deliver inhibition (i.e., to produce Delta) (Collier et al., 1996).
We have previously demonstrated that the capacity of expres-
sion of both Notch1 and Delta-like 1 (Dll1) mRNA in the chick and 
mouse neuroepithelium becomes increased in precursor cells un-
dergoing G2, M, and early G1 (Murciano et al., 2002; Cisneros et al., 
2008) when they are apically located. This temporal expression pat-
tern suggests that lateral inhibition is restricted to neural precursors 
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derived from H2-b2T neuroepithelial cells were created: a control 
cell line transfected with a vector containing the SV40 polyadenyla-
tion sequence downstream of the EGFP coding region (EC cells), 
and two cell lines transfected with the vectors containing the 3′UTRs 
of either Notch1 or Dll1 downstream of the EGFP coding sequence 
(EN and ED cells, respectively).
H2-b2T neuroepithelial cells show characteristics of early neural 
precursors, constituting a good model system for the analysis of 
molecular pathways present in neuroepithelial cells (Nardelli et al., 
2003). Cell-cycle kinetics in these cells was studied using a modifica-
tion of a previously described method based on 5-bromo-2′-
deoxyuridine (BrdU) incorporation during S-phase (Takahashi et al., 
1993). We observed that approximately 30% of the H2-b2T neu-
roepithelial cells incorporated BrdU at the earliest time point ana-
lyzed (1 h), and then they continued incorporating BrdU in a linear 
manner during the first 17 h, a time point at which they reached a 
plateau (Supplemental Figure S1C). These observations allowed us 
to estimate the duration of the cell cycle (TC) and the S-phase (TS), 
concluding that in these cells TC lasts approximately 25 h, whereas 
TS lasts approximately 7.5 h (Supplemental Figure S1, B–D). Further 
analyses indicated that the first mitotic cells that are positively 
stained with BrdU were observed 2 h after addition of this nucle-
otide analog (Supplemental Figure S1A), thus indicating that this 
time is sufficient for these cells to undergo the G2 phase (Supple-
mental Figure S1D). Finally, 1.14% of the H2-b2T neuroepithelial 
cells were observed to undergo M (Supplemental Figure S1A), pro-
viding evidence that this cell-cycle stage lasts <20 min in these cells 
(Supplemental Figure S1D). Because TC occurs in ∼25 h and S+G2+M 
takes place in <10 h, the duration of G1 was calculated to be ap-
proximately 15.5 h (Supplemental Figure S1D). The duration of the 
cell cycle in H2-b2T neuroepithelial cells is in the same range as the 
half-life of EGFP, which has been estimated to last 24 h (Tamberg et 
al., 2007). G1 is therefore long enough to allow a substantial propor-
tion of the EGFP produced during M to become degraded by the 
time the cells undergo S-phase. We conclude therefore that the lev-
els of EGFP in H2-b2T cells can be used as an estimation of the 
cell-cycle–dependent stability of their chimeric mRNAs.
The 3′UTR sequence of Dll1 mRNA facilitates EGFP 
expression during G2/M/early G1
The levels of EGFP expression at different stages of the cell cycle 
were analyzed by flow cytometry in the H2-b2T neuroepithelial cell 
that occupy the apical portion of the neu-
roepithelium. Accordingly, lateral inhibitory 
signaling was observed to be maximal in 
dissociated neural precursors synchronized 
in M (Cisneros et al., 2008). These results 
have been substantiated by independent 
studies demonstrating higher Notch activity 
at the apical portion of the neuroepithelium, 
where neural precursors undergo M (Del 
Bene et al., 2008; Ochiai et al., 2009), thus 
stressing the importance that the three-di-
mensional structure of the neuroepithelium 
has on the neurogenic process (Murciano et 
al., 2002; Xie et al., 2007; Del Bene et al., 
2008; Agathocleous and Harris, 2009; 
Kageyama et al., 2009; Latasa et al., 2009; 
Schenk et al., 2009; Ge et al., 2010).
In our previous work (Cisneros et al., 
2008), we showed that the capacity of neu-
ral precursors to express high levels of 
Notch1 and Dll1 mRNA during M was due to enhanced stability of 
these transcripts at this cell-cycle stage. In the leech Helobdella ro-
busta, the 3′-untranslated region (3′UTR) of Notch mRNA has been 
shown to modulate transcript stability (Gonsalvez and Weisblat, 
2007), likely due to the seven AU-rich elements (AREs) contained in 
its sequence. These elements, often defined by the sequence 
AUUUA, are known to promote mRNA deadenylation and decay (Xu 
et al., 1997; Barreau et al., 2005). In silico analysis demonstrated that 
Notch1 and Dll1 mRNAs contain conserved AREs within their 3′UTRs 
in all species studied (Cisneros et al., 2008), but the question as to 
whether Notch1–3′UTR and Dll1–3′UTR sequences participate in 
cell cycle–dependent stabilization of these transcripts remains unan-
swered.
Several RNA binding proteins (RBPs) can interact with ARE se-
quences and regulate the steady-state levels of their target mRNA 
(Barreau et al., 2005), being potential regulators of Notch1 and Dll1 
stability in the neuroepithelium. We have focused our study on the 
RBP embryonic lethal abnormal vision (Elav)-like 1, also known as 
HuR. Elavl1/HuR can enhance the stability of many mRNAs, includ-
ing the cell-cycle regulators cyclin A, B1, and D1 (Ccna, Ccnb1, and 
Ccnd1) (Wang et al., 2000; Lal et al., 2004), as well as the basic helix-
loop-helix transcription factors MyoD and myogenin (Myod1 and 
Myog) (Figueroa et al., 2003), which are closely related to the 
proneural genes.
RESULTS
Generation of H2-b2T neuroepithelial cells constitutively 
expressing Egfp-Dll1–3′UTR or Egfp-Notch1–3′UTR
We have shown that the transcripts encoding Notch1 and Dll1 are 
differentially expressed along the cell cycle both in the mouse and 
chick neuroepithelia, resulting from the enhancement of the steady-
state levels of these transcripts during M (Cisneros et al., 2008). One 
possibility is that the 3′UTRs of the Notch1 and Dll1 mRNAs, known 
to contain conserved AREs (Cisneros et al., 2008), are required for 
their stabilization during this stage of the cell cycle. To test this pos-
sibility, we created expression vectors containing the 3′UTRs of 
mouse Notch1 or Dll1 downstream of the coding sequence of en-
hanced green fluorescent protein (EGFP) (Figure 1). These con-
structs were transfected in H2-b2T neuroepithelial cells, an immor-
talized cell line established from the hindbrain of mouse transgenic 
embryos expressing a mutated version of the simian virus 40 (SV40) 
T antigen (Nardelli et al., 2003). In total, three polyclonal cell lines 
FIGURE 1: Scheme of the constructs used for creating H2-b2T neuroepithelial cells 
constitutively expressing Egfp-specific transcripts. Transcripts with the SV40 polyadenylation 
sequence (EGFP-control), or with the 3′UTRs of mouse Dll1 (EGFP-Dll1–3′UTR) or Notch1 
(EGFP-Notch1–3′UTR) mRNAs are shown. Note that the Dll1- and Notch1–3′UTR sequences 
have been subcloned at the NotI site of the EGFP-control vector. The SV40 polyadenylation 
signal is not used in these latter constructs as it lies downstream of the Dll1 or Notch1 
polyadenylation signals.
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The 3′UTR sequence of Dll1 confers mRNA stability  
during M
The observed increase of EGFP in ED cells undergoing G2/M/early 
G1 correlates with elevated Egfp mRNA expression. This observa-
tion was evidenced by real-time quantitative PCR (qPCR) analysis on 
cDNA obtained from ED cells synchronized in M, as compared with 
cDNAs from either unsynchronized or S-phase–synchronized ED 
cells (Figure 2H, right panel). We used colchicine for synchronizing 
these cells in M and hydroxyurea (HU) to synchronize them in S-
phase, as previously described (Murciano et al., 2002; Cisneros 
et al., 2008). In contrast, M-synchronized EC cells showed Egfp 
mRNA levels similar to those of EC cells synchronized in S-phase or 
just left unsynchronized (Figure 2H, left panel). Ccnb1 expression 
was observed to be enriched in both EC and ED cells in M (Figure 
2H), thus indicating that our cell synchronization protocol was effec-
tive in these experiments.
To demonstrate that the increase of Egfp during M derives from 
Dll1–3′UTR-dependent mRNA stabilization, mitotically synchronized 
EC or ED cells were treated with actinomycin D to block transcrip-
tion. Subsequently, total RNA obtained from these cells at different 
time points was subjected to qPCR with Egfp-specific primers to 
follow the degradation kinetics of the Egfp transcript. This analysis 
revealed that Egfp mRNA diminished rapidly in the EC cells, whereas 
this transcript was highly stable in the ED cells (Figure 2I). As ex-
pected, Egfp was also rapidly degraded in the EN cells (Figure 2I). 
These data demonstrate that Dll1–3′UTR, but not Notch1–3′UTR, 
induces mRNA stabilization during G2/M/early G1 in neuroepithe-
lium-derived cells.
Elavl1/HuR is expressed by mouse neuroepithelial cells in a 
cell-cycle–dependent manner
Elavl1/HuR is one of a few RBPs known to stabilize their target 
ARE-containing mRNAs (Barreau et al., 2005). As its expression 
pattern in the vertebrate neuroepithelium is currently unknown, we 
decided to perform immunostaining with an Elavl1/HuR-specific 
antibody in telencephalic cryosections obtained from E13.5 mouse 
embryos. This analysis revealed that Elavl1/HuR was highly ex-
pressed in the cytoplasm of fusiform cells located close to the ven-
tricular surface as well as in apically located, round cells undergo-
ing M (Figure 3A). Interestingly, such fusiform cells were not in 
S-phase, as indicated by the absence of BrdU incorporation in 
these cells after a short BrdU pulse (Figure 3A). Elavl1/HuR was 
also detected surrounding the nuclei of apically located precursors 
lacking the mitotic marker pH3 (Figure 3B), suggesting that this 
protein is expressed not only during M but also during late G2 
and/or early G1. These data indicate that Elavl1/HuR becomes en-
riched during M in the cytoplasm of neuroepithelial cells in vivo. 
Elavl1/HuR protein was also observed to be expressed by H2-b2T 
neuroepithelial cells in a cell-cycle–dependent manner, because it 
was enriched in the cytoplasm of H2-b2T neuroepithelial cells un-
dergoing M (i.e., labeled with pH3 specific antibodies) (Supple-
mental Figure S3A). Furthermore, high expression levels of EGFP 
were consistently observed in ED cells showing high Elavl1/HuR 
immunolabeling (Supplemental Figure S3B), suggesting that this 
RBP participates in the stabilization of the Egfp-Dll1–3′UTR tran-
script. To obtain an estimation of the percentage of H2-b2T neu-
roepithelial cells expressing high levels of Elavl1/HuR during M or 
S-phase, these cells were synchronized with colchicine or HU, as 
mentioned earlier in the text. This analysis demonstrated that ap-
proximately 97% of M-synchronized H2-b2T neuroepithelial cells 
expressed Elavl1/HuR at high levels (94 of 97 cells). In contrast, the 
percentage of S-phase–synchronized H2-b2T neuroepithelial cells 
lines stably expressing the different vectors described earlier in the 
text. Cells were grown asynchronously, fixed, and labeled with pro-
pidium iodide (PI) to define the phases of the cell cycle (Figure 2A, 
bottom panels). PI labeling demonstrated that most H2-b2T neu-
roepithelial cells were octoploid (as evidenced by comparison with 
diploid mouse cells that were used as a reference, Supplemental 
Figure S2), with a small subpopulation of cells being tetraploid. This 
observation is consistent with the known polyploidy-inducing effect 
of the SV40 T antigen (Levine et al., 1991). Most H2-b2T neuroepi-
thelial cells were in G1, in accordance with the long duration of this 
cell-cycle stage in these cells (Supplemental Figure S1D), whereas 
the proportion of cells in G2/M was extremely low as expected from 
the cell-cycle kinetics described earlier in the text (Figure 2A, bottom 
panels). Flow cytometry cannot distinguish between tetraploid cells 
in G2/M and octoploid cells in G1. Nevertheless, because the pro-
portion of the former cells is quite reduced, their presence should 
not interfere with the main conclusions of this analysis. Flow cytom-
etry demonstrated that the expression of EGFP in the EC cells was 
highest during late G1 and S-phase, in accordance with the general 
decrease of mRNA stability during M due to cdk1-dependent 
reduction in the activity of poly(A) polymerase (Colgan et al., 1996). 
In contrast, EGFP expression in ED cells was observed to be 
moderately, although nonsignificantly, increased during G2/M 
(3.96 ± 0.40% of ED cells showed high levels of EGFP, whereas 
2.08 ± 0.91% of EC cells contained intense green labeling; n = 3) 
and to be highest during early G1 (7.17 ± 0.36% of ED cells con-
tained intense green labeling, whereas 2.62 ± 0.45% of EC cells 
showed high levels of EGFP; n = 3, p < 0.005; Student’s t test) (Fig-
ure 2A). These results are consistent with a delay in EGFP expression 
after stabilization of its mRNA in ED cells undergoing M. The in-
crease of EGFP expression during G1 was primarily associated with 
tetraploid ED cells (Figure 2B). To confirm the data obtained by flow 
cytometry, EC and ED cells were given a short pulse (1 h) of BrdU. 
This analysis demonstrated that both cell lines showed a similar pro-
portion of BrdU-positive cells (i.e., cells in S-phase) containing high 
levels of EGFP. In contrast, the proportion of ED cells lacking BrdU 
(i.e., in phases of the mitotic cycle other than S) and expressing 
high levels of EGFP was significantly increased as compared with 
this value in the EC cells (Figure 2C; see Figure 2D for an example 
of an ED cell with high EGFP expression).
To study whether these observations are relevant in vivo, we 
performed electroporation experiments in stage HH12 chick em-
bryos (Hamburger and Hamilton, 1951). In these experiments, 
Egfp-Dll1–3′UTR or Egfp-control expression vectors were elec-
troporated into the brain neuroepithelium, and then chick embryos 
were killed 4 h after plasmid delivery. This short time point was 
chosen to avoid accumulation of EGFP, thus restricting the pres-
ence of this protein to neuroepithelial cells recently expressing the 
Egfp transcript. This analysis demonstrated that the presence of 
Egfp-Dll1–3′UTR resulted in a significant increase of apically lo-
cated neuroepithelial cells (i.e., cells in G2/M/early G1) (Murciano 
et al., 2002) positive for EGFP (Figure 2, E and G), when compared 
with the expression pattern resulting from the Egfp-control plas-
mid (Figure 2, E and F).
In contrast to the ED cells, flow cytometric analysis demonstrated 
a general decrease of EGFP expression in the EN cells, which was 
cell-cycle–independent (Figure 2A). These results suggest that the 
3′UTR of Notch1 confers instability to the Egfp chimeric mRNA, as 
previously observed for the 3′UTR of Notch in H. robusta (Gonsalves 
and Weisblat, 2007). In sum, the 3′UTR of Dll1, but not that of 
Notch1, seems to induce mRNA stabilization during G2/M/early G1 
in neuroepithelium-derived cells.
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FIGURE 2: Cell-cycle–dependent regulation of EGFP expression controlled by the 3′UTRs of mouse Notch1 and Dll1 
mRNAs. (A) The levels of expression of EGFP (top panels) was analyzed by flow cytometry in parental H2-b2T 
neuroepithelial cells (Control cells), EC cells, ED cells, or EN cells treated with PI to reveal the amount of DNA. The 
proportion of cells with high EGFP expression (n = 3) increases during both G1 and G2/M in ED cells as compared with 
EC cells (rectangles). The horizontal line represents the threshold below which cells are negative for EGFP expression. PI 
analysis demonstrated that most H2-b2T neuroepithelial cells were octoploid (8C) (see Supplemental Figure S2), 
whereas a small proportion of these cells had a 4C DNA amount (bottom panels). *Note that G1 refers to the octoploid 
cells; all tetraploid cells are included in this interval, but those undergoing S and G2 represent just a minority in absolute 
terms (Supplemental Figure S1D). (B) Distribution of EGFP-positive EC and ED cells (i.e., those present above the 
baseline illustrated in A, top panels) in terms of PI labeling. An increase of EGFP-positive ED cells in G1 (arrows) or G2/M 
(arrowheads) was observed. (C) ED or EC cells were treated with BrdU for 1 h and then fixed and immunostained for 
BrdU. Quantification of ED cells (gray bars) or EC cells (white bars) expressing high levels of EGFP depending on their 
capacity to incorporate BrdU. BrdU+: cells in S-phase; BrdU–: cells in cell-cycle stages other than S-phase. The results 
represent the mean ± SEM (n = 3). *p < 0.05 (Student’s t test). (D) A representative example of ED cells treated with 
BrdU (red) for 1 h. BrdU-negative cells (arrow) express high levels of EGFP (green). Arrowhead: a BrdU-positive cell 
lacking EGFP expression. Bar: 3 μm. (E) Plasmids (1 μg/μl) expressing Egfp-control (open bars, H) or Egfp-Dll1–3′UTR 
(gray bars, I) were electroporated into the brain ventricle of HH12 chick embryos (Hamburger and Hamilton, 1951), and 
4 h later the distribution of EGFP along the apicobasal axis of the neuroepithelium was analyzed. EGFP-positive cells 
were classified into three categories depending of the position of their cell soma within either the basal third, the 
middle of the neuroepithelium, or the apical third. The results represent the mean ± SEM (n = 3); p < 0.005 (two-way 
ANOVA). (F) Representative image of a section throughout the mesencephalon of an HH12 chick embryo 
electroporated with an Egfp-control expression vector. Cell somas are mostly located at the basal portion (arrowhead). 
Arrow: apical surface. v: ventricle. Inset: region inside the dotted square. For a quantification, see E. Bar: 50 μm.  
(G) Representative image of a section throughout the mesencephalon of a HH12 chick embryo electroporated with a 
Egfp-Dll1–3′UTR expression vector. Cell somas are equally located at both the basal portion (arrowhead) and the apical 
surface (arrow). v: ventricle. Inset: region inside the dotted square. For a quantification, see E. Bar: 50 μm. (H) qPCR on 
cDNA obtained from EC or ED cells previously synchronized in M with 1 μg/ml colchicine (Mitosis), in S-phase with 
1 mM HU (S-phase) or left untreated (Asynchr.). Levels of Ccnb1 (open bars, Cyclin B1) or Egfp (gray bars), normalized 
to 18S rRNA, are shown. The results represent the mean ± SEM (n = 3); **p < 0.01; ***p < 0.005 (Student’s t test). (I) EC 
(blue diamonds), ED (green circles), or EN (red triangles) cells were synchronized in M for 24 h with 1 μg/ml colchicine, 
and then transcription was blocked in these cultures with 5 μg/ml actinomycin D for the indicated time points. Levels of 
Egfp mRNA, normalized to 18S rRNA, were then measured in triplicate by qPCR. The results represent the mean ± SEM 
(n = 3). **p < 0.01;***p < 0.005 (Student’s t test).
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Elavl1/HuR and was found as a contaminat-
ing transcript in all IPs (Figure 4A). The as-
sessment of 18S rRNA further ensured that 
equal amounts of cellular lysate were used 
in all IP reactions. Taken together, these re-
sults show that Elavl1/HuR interacts with 
Egfp-Dll1–3′UTR mRNA and thus strongly 
suggest that this RBP controls the steady-
state levels of Dll1 mRNA.
The enrichment of Egfp-Dll1–3′UTR 
mRNA in the samples immunoprecipitated 
with the anti-Elavl1/HuR antibody, com-
pared with the control IPs, was further con-
firmed by qPCR. This analysis demonstrated 
that, in extracts from M-arrested ED cells, 
Egfp mRNA levels (normalized to 18S rRNA) 
were fivefold higher in the Elavl1/HuR IP 
samples than in the control IPs (Figure 4B). 
This effect was specific for the 3′URT-Dll1 
sequence because the levels of Egfp mRNA 
(normalized to 18S rRNA) were not signifi-
cantly augmented in the Elavl1/HuR IP sam-
ples derived from EC cell extracts, com-
pared with the control IPs (Figure 4B). As 
expected, Ccnb1 mRNA was observed to 
specifically interact with Elavl1/HuR in both 
ED and EC cells (Figure 4B).
To directly test the interaction between 
Dll1–3′UTR and Elavl1/HuR, we performed 
RNA pull-down experiments using synthetic digoxigenin-labeled 
(DIG) RNAs added to lysates from H2-b2T cells. Addition of DIG-
Dll1–3′UTR to these extracts, followed by incubation with a digoxi-
genin-specific antibody allowed to pull down the Elavl1/HuR pro-
tein, which was detected by Western blot (Figure 4C). In contrast, 
neither DIG-Notch1–3′UTR nor a DIG-control sequence lacking ARE 
motifs were able to specifically pull down Elavl1/HuR from the H2-
b2T cell lysates (Figure 4C), thus demonstrating the specificity of the 
interaction of this RBP with the Dll1–3′UTR sequence.
Finally, the interaction of endogenous Dll1 mRNA with Elavl1/
HuR was demonstrated to occur in primary neuronal precursor cells. 
IP performed in lysates of E12 brain precursors synchronized in M, 
followed by qPCR (Figure 5, A and B), demonstrated that Dll1 mRNA 
(normalized to 18S rRNA) was threefold increased in the Elavl1/HuR 
IP samples compared with the control IPs. This pattern was similar to 
that of Ccnb1 mRNA (Figure 5, A and B).
RNAi against Elavl1 reduces the steady-state levels of Egfp 
mRNA in ED cells synchronized in M
To study the effect of Elavl1/HuR on the steady-state levels of Dll1 
mRNA in the H2-b2T neuroepithelial cells, two pairs of RNAi con-
structs against sequences specific for Elavl1 mRNAs were cloned in 
the pSilencer 1.0-U6 plasmid. The capacity of these constructs to 
interfere with Elavl1 was evaluated by transient transfection along 
with red fluorescent protein (RFP) in H2-b2T neuroepithelial cells 
synchronized in M, followed by immunostaining with Elavl1/HuR an-
tibodies. Then the proportion of RFP-positive H2-b2T neuroepithe-
lial cells expressing Elavl1/HuR was estimated in these cultures. This 
analysis demonstrated that Elavl1-specific RNAi constructs signifi-
cantly reduced the expression of Elavl1/HuR in M-synchronized 
H2-b2T neuroepithelial cells when compared with the control pSi-
lencer 1.0-U6 plasmid (Figure 6A and Supplemental Figure S5A). 
The capacity of the Elavl1-specific RNAi constructs to reduce the 
expressing Elavl1/HuR was reduced (14 cells of 129 S-phase–syn-
chronized cells expressed this RBP). The cell-cycle-dependent ex-
pression of Elavl1/HuR both in vivo and in the H2-b2T neuroepi-
thelial cells, along with the presence of this protein in the cytoplasm, 
strongly suggests that it may prevent mRNA degradation in neu-
roepithelial cells at stages of the cell cycle different from S-phase, 
thus becoming a strong candidate for the stabilization of Dll1 
mRNA during G2/M/early G1.
Elavl1/HuR is able to interact with mouse Dll1–3′UTR
We thus tested whether Elavl1/HuR can interact with the 3′UTR of 
mouse Dll1 mRNA. Because the Egfp sequence does not contain 
AREs (accession number U55762; Figure 1), we reasoned that any 
interaction of the Egfp-Dll1–3′UTR mRNA with this RBP should de-
pend on the Dll-3′UTR sequence. The endogenous association be-
tween Elavl1/HuR and Egfp-Dll1–3′UTR mRNA was analyzed in M-
arrested ED cells by means of ribonucleoprotein complex IP (RNP-IP) 
assays using the anti-Elavl1/HuR monoclonal antibody (mAb) 3A2 
followed by reverse transcriptase (RT)-PCR–based detection of the 
Egfp-Dll1–3′UTR mRNA. Although, theoretically, the 3A2 mAb can 
recognize all members of the Elavl/Hu family, in these experiments 
it only identifies Elavl1/HuR because the other neuronal Elavl/Hu 
members (Elavl2/HuB, Elavl3/HuC, and Elavl4/HuD) are not de-
tected in the ED cells, even after performing 35 rounds of RT-PCR 
amplification (Supplemental Figure S4). Association between Elavl1/
HuR and Egfp-Dll1–3′UTR mRNA was evidenced by a strong enrich-
ment of Egfp-Dll1–3′UTR mRNA in Elavl1/HuR IP samples compared 
with IgG control IP (Figure 4A). As a positive control, we tested the 
association between Elavl1/HuR and endogenous Ccnb1, an mRNA 
the stability of which is known to be regulated by Elavl1/HuR (Wang 
et al., 2000; Lal et al., 2004). Ccnb1 mRNA was detected in anti-
Elavl1/HuR antibody IP but not in control IgG IP (Figure 4A). A fur-
ther control included detection of 18S rRNA, which is not a target of 
FIGURE 3: Expression of Elavl1 in the embryonic murine cortex. (A) Cortical cryosections 
(15 μm) from E13.5 mouse previously treated with BrdU for 1 h immunostained for Elavl1/HuR 
(red) and BrdU (green), counterstained with bisbenzimide (Bisb.) to localize the nuclei (blue). 
Cells expressing Elavl1/HuR at high levels are located close to the ventricle (arrows), and they 
do not incorporate BrdU. (B) Cortical cryosections (15 μm) from E13.5 mouse immunostained for 
Elavl1/HuR (red) and pH3 (green), counterstained with bisbenzimide (Bisb.) to define the nuclei 
(blue). Most cells expressing Elavl1/HuR close to the ventricle are not in M. All cells in M show 
Elavl1/HuR immunoreactivity (arrows). V: ventricle; bar: 5 μm (A), 10 μm (B).
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ED cells expressing EGFP (Figure 6B), as compared with the ED cells 
transfected with the control pSilencer 1.0-U6 plasmid. These results 
are in sharp contrast with those obtained in M-synchronized EC cells 
where Elavl1-specific RNAi constructs did not alter the proportion of 
cells expressing EGFP (Figure 6C).
In some instances, Elavl1/HuR has been shown to enhance trans-
lation (Mazan-Mamczarz et al., 2003). To verify that the observed 
reduction of EGFP levels in response to the Elavl1-specific RNAi 
construct was due, at least partially, to a reduction of the steady-
state levels of the Egfp-Dll1–3′UTR mRNA, ED cells were cotrans-
fected with RFP along with either Elavl1 RNAi or the control RNAi 
construct. Then these cells were synchronized in M for 24 h and ei-
ther left untreated or subjected to a 4-h treatment with actinomycin 
D to block transcription. Those cells expressing high levels of RFP 
(i.e., with high levels of Elavl1-specific RNAi) were subsequently iso-
lated by FACS, and the levels of Egfp mRNA (normalized to 18S 
rRNA) were estimated by qPCR. This analysis demonstrated that the 
interference against Elavl1 resulted in a significant reduction of Egfp 
mRNA levels after 4-h treatment with actinomycin D, as compared 
with the control situation (Supplemental Figure S6). Taken together, 
these results stress the importance of Elavl1/HuR for maintaining 
high levels of Dll1–3′UTR–containing transcripts in the H2-b2T neu-
roepithelial cells.
Reduced Dll1 mRNA levels in the developing brain of 
Elavl1/HuR knockout mice
We next studied the capacity of Elavl1/HuR to enhance the steady-
state levels of Dll1 mRNA in vivo. To this end, we compared the 
levels of Dll1 mRNA expression in brains from E10.5 wild-type (WT) 
or Elavl1 heterozygous knockout (Elavl1+/−) embryos. Elavl1 knock-
out mice lack exon 2 from the Elavl1 murine gene, which contains 
the ATG for the initiation of translation. This mutation results in the 
absence of Elavl1/HuR protein expression and embryonic lethality 
from E10.5 to E12.5 due to placental failure (Katsanou et al., 2009). 
At E10.5, Elavl1−/– mice display a developmental lag of ∼1.0–1.5 d 
postcoitum (Katsanou et al., 2009). Because this delay could com-
promise the analysis of developmental-dependent gene expression 
in Elavl1−/– mice due to differences in brain maturation, we decided 
to focus the study on WT versus Elavl1+/− mice littermates, which 
display no morphological abnormalities when compared with each 
other (Katsanou et al., 2009). Both RT-PCR (Figure 6D) and qPCR 
(Figure 6E) analysis revealed that Dll1 mRNA expression was re-
duced in the brain of Elavl1+/– mice, in parallel with a decrease in 
Ccnb1 mRNA expression levels. Altogether, these results indicate 
that reducing Elavl1/HuR expression (either by knockdown or knock-
out) affects the level of Dll1 mRNA expression.
Elavl1 RNAi reduces the capacity of brain precursors to 
trigger Dll1-dependent lateral inhibitory signals
Neurogenesis is controlled by lateral inhibitory signals triggered by 
the Delta/Notch signaling pathway. This mechanism amplifies and 
stabilizes any stochastic difference in Dll1 expression between 
neighbor cells, thus resulting in neuronal differentiation of precur-
sors with higher amount of Dll1 (Louvi and Artavanis-Tsakonas, 
2006). It is therefore expected that any manipulation aimed to re-
duce Dll1 expression in a neural precursor surrounded by normal 
precursor cells should result in its inability to differentiate due to an 
increase of lateral inhibitory signals delivered by adjacent cells. To 
analyze the capacity of Elavl1/HuR to regulate this process, 
Elavl1-specific RNAi constructs were coelectroporated along with 
RFP in brain precursors from E12 mouse embryos, which subse-
quently were cocultured for 18 h with nontransfected E12 brain 
expression of Elavl1/HuR in H2-b2T neuroepithelial cells was con-
firmed by Western blot analysis in cell extracts from H2-b2T cells li-
pofected with RFP plus either the Elavl1-specific RNAi construct or 
the control vector, and then mitotically synchronized with colchicine. 
To avoid the presence in the cell extracts of Elavl1/HuR expressed in 
nonlipofected cells, RFP-positive cells were isolated by fluorescence-
activated cell sorting (FACS) and then used for protein extraction. 
This analysis demonstrated that the levels of Elavl1/HuR become 
reduced in cells expressing the Elavl1-specific RNAi construct 
(Supplemental Figure S5B). Importantly, decreased Elavl1/HuR ex-
pression is correlated with a decreased number of M-synchronized 
FIGURE 4: Binding of Elavl1/HuR to the Dll1–3′UTR sequence. 
Extracts from ED (A and B) or EC (B) cells synchronized in M were 
used for RNP-IP analysis. (A) The association of endogenous Elavl1/
HuR (HuR) with Ccnb1 (Cyclin B1) and Egfp-Dll1–3′UTR (Egfp) was 
tested by RT-PCR after IP with an anti-Elavl1/HuR antibody. Mouse 
IgG was used as a control for IP. RNA extracted from cell lysates 
before IP (Input) was amplified in parallel. Amplification of 
contaminating traces of 18S rRNA was performed as an internal 
control. (B) Verification by qPCR of the association between 
endogenous Elavl1/HuR and Ccnb1 (Cyclin B1) or Egfp-Dll1–3′UTR 
(Egfp) after IP with an anti-Elavl1/HuR antibody (αHuR) in cell extracts 
from EC or ED cells. Mouse IgG was used as a control for IP. RNA 
extracted from cell lysates was converted to cDNA and amplified to 
show the levels of the analyzed RNAs (normalized to 18S rRNA). The 
results represent the mean ± SEM (n = 3). **p < 0.01; ***p < 0.005 
(Student’s t test). (C) Digoxigenin-based pull-down assay using lysates 
prepared from H2-b2T cells. The binding of HuR to the DIG Dll1–
3′UTR (Dll1 3′UTR) sequence was specific. In contrast, HuR did not 
bind either an irrelevant DIG sequence (Control) or the DIG Notch1–
3′UTR sequence (Notch1 3′UTR).
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tion of the neuroblastic layer located inside 
the neurogenic region. This analysis indi-
cated that a small, although significant, in-
crease in the proportion of βIII tubulin–posi-
tive cells can be observed in the Elavl1 
heterozygous embryos, as compared with 
their control littermates (Figure 8, C–E).
DISCUSSION
The RBP Elavl1/HuR is believed to have 
ubiquitous expression patterns in most tis-
sues (Ma et al., 1996; Lu and Schneider, 
2004). We have further analyzed the ex-
pression of this RBP in the developing neu-
roepithelium. This analysis demonstrated 
that Elavl1/HuR displays a distinct expres-
sion pattern, with strong cytoplasmic local-
ization in apically located cells. It was also 
detected in apically located, fusiform neu-
roepithelial cells that do not incorporate 
BrdU, resembling the expression pattern of 
Dll1-positive cells in the mouse developing 
brain (Cisneros et al., 2008). Elavl1/HuR has 
been shown to be primarily localized to the nucleus of NIH-3T3 
cells, but in response to different stimuli it can shuttle to the cyto-
plasm (Atasoy et al., 1998), thus protecting its target mRNAs from 
degradation (Fan and Steitz, 1998; Doller et al., 2008; Kim and 
Gorospe, 2008). The expression pattern of Elavl1/HuR is consis-
tent with its ability to enhance the steady-state levels of specific 
transcripts in neural precursors undergoing M, including those 
from Dll1. Interestingly, Elavl1/HuR function is linked to the cell 
cycle. As such, this RBP has the capacity to modulate the expres-
sion of key cell-cycle regulators (Barreau et al., 2005). Furthermore, 
Elavl1/HuR can undergo cell-cycle–dependent regulation because 
it can be phosphorylated by the G2/M-specific kinase Cdk1, thus 
leading to retention of this RBP in the nucleus of HeLa cells (Kim 
et al., 2008). In contrast with this finding, we have observed in vivo 
and in vitro that neuroepithelial cells are characterized by cyto-
plasmic translocation of Elavl1/HuR during M, indicating a com-
plex regulation of nuclear export of this RBP.
We have shown that Elavl1/HuR can interact with Egfp-Dll1–
3′UTR mRNA in H2-b2T neuroepithelial cells synchronized in M. 
This interaction likely takes place through the Dll1–3′UTR se-
quence because Egfp does not contain AREs in its sequence and 
a synthetic Dll1–3′UTR RNA can specifically pull down Elavl1/HuR 
from H2-b2T neuroepithelial cell lysates. Furthermore, we have 
presented evidence that Elavl1/HuR can interact with endogenous 
Dll1 mRNA in E12 brain precursors, indicating that the observed 
interaction between Elavl1/HuR and Dll1–3′UTR is functionally sig-
nificant. From the RNP-IP experiments performed in lysates of E12 
neuronal precursors, we cannot exclude that Dll1 mRNA could in-
teract with Elavl2/HuB, Elavl3/HuC, and Elavl4/HuD, because the 
anti-Elavl1/HuR antibody used for these assays can recognize 
these other members of the Elavl/Hu family. Nevertheless, Elavl2/
HuB, Elavl3/HuC, and Elavl4/HuD are mainly expressed in the dif-
ferentiated layers of the embryonic brain (see Gene Expression 
Nervous System Atlas at www.ncbi.nlm.nih.gov/projects/gensat/), 
whereas Dll1 is restricted to the neuroepithelium at these embry-
onic stages (Lindsell et al., 1996; Cisneros et al., 2008). The ex-
pression patterns of Elavl2/HuB, Elavl3/HuC, and Elavl4/HuD sug-
gest that Elavl1/HuR is the major Elavl/Hu member interacting 
with Dll1 in the undifferentiated neuroepithelium.
precursors at high density to allow lateral inhibition to take place. 
Cells were then fixed and immunostained with anti-βIII tubulin–
specific antibodies to reveal neuronal commitment. Cells were clas-
sified as positive for this marker when βIII tubulin–positive immunos-
taining was observed clearly surrounding the nucleus, which was 
labeled with bisbenzimide. The percentage of βIII tubulin–positive 
neurons was significantly diminished in brain precursors expressing 
Elavl1-specific RNAi constructs, as compared with precursors trans-
fected with the control plasmid (Figure 7, B and D). The reduced 
neurogenic capacity of Elavl1 RNAi-transfected cells is likely to de-
rive from their diminished capacity to deliver lateral inhibitory sig-
nals to their neighbors due to decreased expression of Dll1, and not 
from side effects on alternative signaling pathways involved in the 
process of neurogenesis. To test this hypothesis, brain precursors 
were cotransfected with an expression vector containing the coding 
sequence of Dll1 together with the Elavl1-specific RNAi constructs. 
Expression of Dll1 significantly increased the proportion of brain 
precursors showing βIII tubulin–specific immunoreactivity in the 
presence of Elavl1-specific RNAi (Figure 7, C and D). Altogether 
these results indicate that Elav1/HuR is necessary for Dll1-depen-
dent lateral inhibition to occur, likely through regulation of Dll1 
expression.
Elavl1+/− embryos show increased neuronal production in 
the developing retina
To confirm in vivo that the absence of Elavl1/HuR reduces the ca-
pacity of neuronal precursors to trigger lateral inhibitory signals, 
thus favoring neuronal differentiation, we focused on the E12.5 
mouse retina. At this early stage, the retina contains two major lay-
ers: the ganglion cell layer (GCL), which contains differentiated reti-
nal ganglion cells, and the neuroblastic layer, constituted by prolif-
erating neuroepithelial cells and recently born neuroblasts migrating 
to the GCL (Figure 8, A–D). In addition, a differentiation gradient 
exists in this tissue that restricts neurogenesis to its most central por-
tion (illustrated in Figure 8, A and B, as the neurogenic region lo-
cated between the two yellow lines). The rate of neurogenesis in this 
tissue was estimated as the proportion of differentiating neurons 
(i.e., βIII tubulin–positive cells) with respect to the total number of 
cells (i.e., bisbenzimide-labeled nuclei) that are present in the por-
FIGURE 5: Binding of Elavl1/HuR to Dll1 in E12 brain precursor cells. Extracts from E12 brain 
precursor cells synchronized in M were used for RNP-IP analysis. (A) The association of 
endogenous Elavl1/HuR (HuR) with Ccnb1 (Cyclin B1) and Dll1 (Dll1) was tested by RT-PCR after 
IP with an anti-Elavl1/HuR antibody. Mouse IgG was used as a control for IP. RNA extracted from 
cell lysates before IP (Input) was amplified to show the expression levels of the analyzed RNAs. 
Amplification of contaminating traces of 18S rRNA was performed as an internal control. 
(B) Verification by qPCR of the association between endogenous Elavl1/HuR and Ccnb1 (Cyclin 
B1) or Dll1 (Dll1) after IP with an anti-Elavl1/HuR antibody (αHuR) in lysates from E12 brain 
precursor cells. Mouse IgG was used as a control for IP. RNA extracted from immunoprecipitates 
was converted to cDNA and amplified to show the levels of the analyzed RNAs (normalized to 
18S rRNA). The results represent the mean ± SEM (n = 3). *p < 0.05 (Student’s t test).
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mRNA stabilization because Elavl1-specific RNAi reduces the levels 
of Egfp-Dll1–3′UTR transcript in these cells. These observations are 
consistent with the enhanced capacity of apically located precursors 
to express Dll1 in vivo (Murciano et al., 2002; Cisneros et al., 2008), 
concomitant with the expression of Elavl1/HuR in these cells. This 
role seems to be conserved through evolution, because we provide 
evidence that the murine Dll1–3′UTR sequence is also functional in 
chick neuroepithelial cells in vivo. In contrast, the presence of the 
3′UTR of Notch1 mRNA correlated with reduced expression levels 
of EGFP in EN cells, supporting the conclusion that the Dll1–3′UTR 
sequence specifically confers mRNA stability during M.
Our data demonstrate an enhancement of the steady-state lev-
els of both EGFP and Egfp mRNA in ED cells undergoing M when 
compared with control H2-b2T cells. This effect is likely due to 
FIGURE 7: RNAi against Elavl1 results in Dll1-dependent decreased 
neurogenesis. Neuronal precursors from E12 mouse brain were 
coelectroporated with different plasmid combinations, including a 
Dll1 expression vector and an Elavl1/HuR-specific RNAi vector plus 
RFP (red), and cultured at high density (200,000 cells/cm2) to allow 
cell–cell contacts and lateral inhibition to occur. After 18 h, the cells 
were fixed and immunostained with anti–βIII tubulin antibodies 
(green), known to specifically label neurons. Nuclei were 
counterstained with bisbenzimide (blue). (A) An example of cells 
transfected with control plasmids (arrows) showing βIII tubulin–
specific immunoreactivity. (B) An example of a cell transfected with 
the Elavl1/HuR-specific RNAi vector (arrowhead) lacking βIII tubulin–
specific immunoreactivity. (C) An example of cells transfected with the 
Dll1 expression vector and the Elavl1/HuR-specific RNAi vector. Most 
cells showed βIII tubulin–specific immunoreactivity (arrows). A 
transfected cell lacking βIII tubulin–specific immunoreactivity is 
indicated (arrowhead). (D) In the presence of the Elavl1/HuR-specific 
RNAi vector, the proportion of βIII tubulin–positive neurons was 
significantly reduced (see arrowhead in B). The expression of Dll1 
significantly increased the proportion of brain precursors showing βIII 
tubulin–specific immunoreactivity, an effect that could not be reduced 
by the Elavl1/HuR-specific RNAi vector. *p < 0.05; ***p < 0.005 (n = 3; 
Student’s t test). Bar: 10 μm (A and B), 14 μm (C).
FIGURE 6: Elavl1 regulates Dll1 expression both in vitro and in vivo. 
(A) Parental H2-b2T neuroepithelial cells (Control cells) were 
cotransfected with RFP and a pSilencer-Elavl1 RNAi construct (HuR 
RNAi) or a control pSilencer 1.0-U6 plasmid (Control), and then 
synchronized in M with 1 μg/ml colchicine. Shown are the percentages 
of RFP-positive cells expressing high levels of Elavl1/HuR in both 
conditions. Normalized data are presented. ***p < 0.005 (n = 3; 
Student’s t test). (B) ED cells were transfected with RFP and a 
pSilencer-Elavl1 construct (HuR RNAi) or a control pSilencer 1.0-U6 
plasmid (Control) and then synchronized in M with 1 μg/ml colchicine. 
The percentage of cells expressing high levels of EGFP in both 
situations is shown. ***p < 0.005 (n = 3; Student’s t test). (C) EC cells 
were transfected with RFP and a pSilencer-Elavl1 construct (HuR 
RNAi) or a control pSilencer 1.0-U6 plasmid (Control), and then 
synchronized in M with 1 μg/ml colchicine. The percentage of cells 
expressing high levels of EGFP in both situations is shown (n = 3). 
N.S.: non significant. (D) cDNA obtained from E10.5 brains of 
heterozygous Elavl1/HuR null-mutant mice (+/−) or WT mice (+/+) was 
used for PCR amplification using primers specific for Dll1 (Delta1), 
Ccnb1 (Cyclin B1), Elavl1 (HuR), or 18S rRNA (18S rRNA). (E) cDNA 
obtained from E10.5 brains of heterozygous Elavl1/HuR null-mutant 
mice (+/−) or WT mice (+/+) was used for qPCR using primers specific 
for Dll1 (Delta1), Ccnb1 (Cyclin B1), or Elavl1 (HuR). Values were 
normalized to 18S rRNA. The results represent the mean ± SEM 
(n = 4); *p < 0.05; **p < 0.001; ***p < 0.005 (Student’s t test).
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Notch1 mRNA is rapidly degraded in the ab-
sence of stabilizing RBPs in cells undergoing 
S-phase.
Our study provides genetic evidence for 
the involvement of Elavl1/HuR in the stabi-
lization of Dll1 mRNA. As such, the expres-
sion of this gene was observed to be down-
regulated in the brain of E10.5 mouse 
embryos containing one null allele for mu-
rine Elavl1 (Katsanou et al., 2009). At this 
stage, most of the brain-specific Dll1 tran-
scripts are restricted to the neuroepithelium 
(Lindsell et al., 1996; Cisneros et al., 2008). 
Therefore genetic evidence supports the 
hypothesis that Elavl1/HuR is required for 
stabilization of Dll1 in neural precursors un-
dergoing M, thus facilitating Delta/Notch 
signaling in these cells. Elavl1 deficiency 
also caused a reduction of Ccnb1 mRNA 
expression. Although this observation may 
suggest that part of the effect observed on 
Dll1 expression is due to reduced prolifera-
tive capacity of the neuroepithelial cells, it 
is important to stress that no gross morpho-
logical alterations are observed in the 
heterozygous mice (Katsanou et al., 2009). 
Interference against Elavl1 mRNA in M-syn-
chronized ED cells also resulted in the de-
crease of the levels of EGFP-Delta1–3′UTR 
mRNA, further indicating that Elavl1/HuR 
has an intrinsic capacity to stabilize Dll1 
during M.
Interference against Elavl1 mRNA corre-
lated with reduced capacity of brain precur-
sors to deliver lateral inhibitory signals. This 
effect, observed in RNAi-transfected precur-
sors cocultured at high density with non-
transfected precursor cells, is likely to de-
pend on the destabilization of Dll1 mRNA 
resulting from reduced Elavl1/HuR expres-
sion because Dll1 overexpression prevented 
the effect of Elavl1 interference on lateral 
inhibition. These results were confirmed by 
using a genetic approach, as we have shown 
that Elavl1 heterozygous mice exhibit in-
creased neuronal production in the devel-
oping retina, in accordance with the reduc-
tion of Dll1 expression observed in the developing nervous system 
of these mice. Such a reduction of Dll1 expression in Elavl1 heterozy-
gous mice is likely to enhance proneural gene expression in precur-
sor cells, thus favoring neuronal differentiation. Because no obvious 
phenotype has been detected in the Elavl1 heterozygous mice 
(Katsanou et al., 2009), neuronal overproduction in these mice could 
be counterbalanced by programmed cell death at later stages of 
development.
In sum, our results stress the importance of Elavl1/HuR in verte-
brate neurogenesis, a concept that was previously unsuspected 
despite the importance of the Elav locus for the development and 
maintenance of the nervous system in Drosophila (Robinow et al., 
1988). Unlike Elav, which is expressed by postmitotic neurons, 
Elavl1/HuR has an important role in mitotic neural precursors as it 
regulates Delta/Notch signaling in apical neuroepithelial cells. Dll1 
Notch1–3′UTR–induced mRNA destabilization occurs at all stages 
of the cell cycle and seems to be independent of Elavl1/HuR be-
cause this RBP does not interact with the Notch1–3′UTR sequence in 
pull-down assays. Nevertheless, we cannot rule out that the appar-
ent lack of interaction between Elavl1/HuR and the 3′UTR of Notch1 
in vitro may be due to competition of the Notch1–3′UTR sequence 
with other RBPs or with specific micro RNAs. The dramatic inhibition 
of EGFP expression triggered by the 3′UTR of Notch1 in EN cells is 
consistent with the observation that the Notch-3′UTR sequence is 
sufficient for degradation of zygotic Notch in the leech Helobdella 
robusta (Gonsalves and Weisblat, 2007). Our data are also consistent 
with the expression pattern of Notch1 mRNA in the vertebrate 
neuroepithelium in vivo, which is basically absent from the 
basal neuroepithelial cells (Murciano et al., 2002; Cisneros et al., 
2008). Its absence from the basal neuroepithelium suggests that 
FIGURE 8: Neuronal production is enhanced in the differentiating retina of Elavl1+/– mice. 
Retinal cryosections (15 μm) from E12.5 mouse embryos (A and C: WT mice; B and D: Elavl1 
heterozygous mice) immunostained for βIII tubulin (red in A–D), and counterstained with 
bisbenzimide (blue in A and B) to reveal cell nuclei. (A) A cryosection of a WT retina (+/+) is 
shown. The dotted line represents the boundary between the ganglion cell layer (gcl) and the 
neuroblastic layer (nl). Yellow lines represent the boundaries between the neurogenic region in 
the central retina, where βIII tubulin–positive cells can be observed, and the nonneurogenic 
region in the peripheral retina, a region lacking βIII tubulin expression. (B) A cryosection of a 
Elavl1+/− retina (+/−) is shown. For specific details, see A. (C) Inset shown in A. (D) Inset shown in 
B. (E) Percentage of differentiating βIII tubulin–positive neuroblasts present in the neuroblastic 
layer located within the neurogenic region (surrounded by the yellow lines in A and B). pe: 
pigment epithelium; v: vitreous body; l: lens. Arrows in C and D: βIII tubulin–positive cells. 
***p < 0.005 (n = 4; Student’s t test). Bar: 50 μm (A and B), 16 μm (C and D).
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RT-PCR
mRNA was extracted using the QuickPrep Micro mRNA purifica-
tion kit (GE Healthcare, San Diego, CA), from which cDNA was pre-
pared using the First-Strand cDNA Synthesis Kit (GE Healthcare). 
Total RNA was extracted with TRIzol Reagent (Invitrogen), 
and reverse transcribed with Superscript II RNase H- Reverse 
Transcriptase (Invitrogen). Amplification of cDNAs was performed 
using standard procedures, and data were obtained when amplifica-
tion was linear. Amplifications performed in the absence of reverse 
transcriptase lacked any specific band. The PCR primers used 
(Supplemental Table S1) were Dll1 up2 and Dll1 down2 for Dll1, 
Elavl1 up and Elavl1 down for Elavl1/HuR, Elavl2 up and Elavl2 
down for Elavl2/HuB, Elavl3 up and Elavl3 down for Elavl3/HuC, 
Elavl4 up and Elavl4 down for Elavl4/HuD, Ccnb1 up and Ccnb1 
down for Ccnb1, Egfp up and Egfp down for Egfp, and 18S rRNA 
up and 18S rRNA down for 18S rRNA.
qPCR
Total RNA from dissociated neuroepithelial cell cultures, from 
E10.5 brain, or from immunoprecipitated material was extracted 
using TRIzol Reagent (Invitrogen). Using 100 ng of this total 
RNA sample as a template, cDNAs were prepared with Super-
Script II Reverse Transcriptase (Invitrogen) in 20-μl reactions. 
The RT-PCR reactions were run in triplicate on 96-well reaction 
plates with SYBR Green PCR Master Mix (Applied Biosystems, 
Carlsbad, CA), using an ABI PRISM 7700 Sequence Detection 
System (Applied Biosystems). The qPCR reaction was performed 
with 1 μl of cDNA for Egfp, Ccnb1, Dll1, and Elavl1, or with 1 μl 
of a 10-fold dilution for 18S rRNA to normalize the mRNA levels 
(Schmittgen and Zakrajsek, 2000). The primers (0.2 μM) used 
for qPCR (Supplemental Table S1) were Egfp forward and Egfp 
reverse for Egfp, Ccnb1 forward and Ccnb1 reverse for Ccnb1, 
Dll1 forward and Dll1 reverse for Dll1, 18S forward and 18S 
reverse for 18S rRNA, and Elavl1 forward and Elavl1 reverse for 
Elavl1. More than 40 cycles of amplification were performed, 
including a denaturation (95°C; 15 s) and annealing/extension 
(60°C; 1 min) step. Data acquisition and the analysis of the 
qPCR assays were performed using the 7000 System SDS Soft-
ware (Version 1.2.3; Applied Biosystems). SYBR Green/dsDNA 
complex signal was normalized to the passive reference dye 
(ROX) during data analysis to correct for nonPCR-related well-
to-well fluorescent fluctuations.
RNP-IP
IP of endogenous Elavl1-mRNA complexes was performed as pre-
viously described (Lal et al., 2004) with the following modifica-
tions. Briefly, PBS-washed pellets from 20 × 106 Dll1-H2-b2T neu-
roepithelial cells or 2 × 107 E12 brain cells, synchronized in M, 
were resuspended in 600 μl of RSB (50 mM Tris-HCl, pH 7.4, 
50 mM KCl, 10 mM magnesium acetate) plus 200 μl of glass 
beads (Sigma), vortexed twice for 30 s, and centrifuged for 10 min 
at 3000 rpm in a minifuge. Protease (Roche) and RNAse inhibitors 
(rRNAsin; Promega) were added. The supernatant was precleared 
with Protein A sepharose beads (Sigma) for 1 h at 4°C. Half of the 
supernatant was incubated with antibody-coated, prewashed Pro-
tein A sepharose beads (20 μg of anti-Elavl1/HuR mAb 3A2 or 
control IgG) and left overnight at 4°C. The beads were washed 
five times in RSB complemented with protease and RNAse 
inhibitors. Total RNA in the immunoprecipitated material or 
input cytoplasmic extracts was extracted with TRIzol Reagent, 
and RT-PCR or qPCR amplified. The presence of contaminating 
traces of RNAs that do not interact with the studied RBPs is 
mRNA stabilization may contribute to the maintenance of the Delta 
ligand in differentiating neuroblasts as they initiate their migration 
to the differentiated brain regions.
MATERIALS AND METHODS
Mice
C57BL6/J and Elavl1 mice (Katsanou et al., 2009) were used 
in this study. Elavl1 genotypes were determined by genomic PCR 
as previously described (Katsanou et al., 2009). Experimental 
procedures were approved by the CSIC and CNRS animal ethics 
committees.
Primary antibodies
The anti-Elavl1/HuR mouse mAb 19F12 (CLONEGENE, Hartford, 
CT) was diluted 500-fold (immunocytochemistry and immunohis-
tochemistry). The anti-Elavl1/HuR mAb 3A2 (from I. Gallouzi, 
McGill University) was used at 1:500 (vol:vol) (Western blot). The 
rabbit anti-GFP polyclonal antiserum (Invitrogen, Carlsbad, CA) 
was used at 1:1000 (vol:vol) (immunocytochemistry). The anti-BrdU 
mouse mAb G3G4 (Developmental Studies Hybridoma Bank 
[DSHB], University of Iowa, Iowa City, IA) was diluted 4000-fold. 
The anti-BrdU rat mAb BU1/75 (ICR1; AbD Serotec, Raleigh, NC) 
was used at 1:200 (vol:vol). The mouse mAb against neuron-spe-
cific βIII tubulin (clone 5G8; Millipore, Billerica, MA) was diluted 
1000-fold (immunohistochemistry) or 10,000-fold (Western blot). 
The anti-phospho-Histone H3 (pH3) rabbit polyclonal antibody 
(Upstate Biotechnology, Lake Placid, NY) is a well-characterized 
marker of M, and it was diluted 1:400 for immunostaining. The 
anti-digoxigenin mAb (Roche, Basel, Switzerland) was used at 
1:500 (vol:vol) dilution for pull-down experiments.
Plasmids
The pEGFP-N1 expression vector (Clontech, Mountain View, CA) 
was used to generate the pEGFP-Notch1–3′UTR and pEGFP-Dll1–
3′UTR vectors. The Notch1–3′UTR sequence was amplified with 
Pfu DNA polymerase (BioTools, Jupiter, FL) from a plasmid con-
taining full-length Notch1 (Hansson et al., 2006) using the Notch1 
up and Notch1 down oligonucleotides (Supplemental Table S1). 
The Dll1–3′UTR sequence was amplified with Pfu DNA polymerase 
(BioTools) from E13.5 mouse brain cDNA using the Dll1 up1 and 
Dll1 down1 oligonucleotides (Supplemental Table S1). The ampli-
fied fragments were sequenced, cloned into the pGEM-Teasy vec-
tor (Promega, Madison, WI), and subcloned into the NotI site of 
pEGFP-N1, thus giving rise to the pEGFP-Notch1–3′UTR and 
pEGFP-Dll1–3′UTR vectors, respectively. The pSilencer 1.0-U6 
siRNA vector (Ambion, Austin, TX) was used to construct vectors 
to interfere with mouse Elavl1 (accession number NM_010485), us-
ing as target sequences: base pairs 265–283 (pSilencer-Elavl1/1) 
and base pairs 1130–1148 (pSilencer-Elavl1/2). Two oligonucle-
otide pairs were used to generate the target sequences (Elavl1/1 
sense and Elavl1/1 antisense; Elavl1/2 sense and Elavl1/2 anti-
sense) (Supplemental Table S1), following the instructions of the 
manufacturer. The RFP-expressing vector pRFPRNAiC was pro-
vided by Stuart Wilson (Das et al., 2006). A pCEP4 expression vec-
tor containing the full-length sequence of mouse Dll1 (pCEP4-Dll1) 
was provided by Kohzo Nakayama (Shinshu University, Nagano, 
Japan). 
In vivo BrdU treatment
Pregnant female C57BL6/J mice were intraperitoneally injected with 
BrdU in phosphate-buffered saline (PBS; 50 μg/g body weight) and 
killed 1 h later.
Volume 22 April 15, 2011 Dll1 mRNA stabilization by Elavl1/HuR | 1237 
commonly used as a negative control for the RNP-IP assays (Lal 
et al., 2004; López de Silanes et al., 2004). In this study, 18S rRNA 
was used as a negative control.
In vitro RNA pull-down assay
DIG RNA corresponding to the 3′ UTR sequences of mouse Notch1 
or mouse Dll1, or an irrelevant sequence lacking ARE motifs (base 
pairs 347–804, accession number AF032966), was synthesized by 
using the DIG RNA-labeling kit (Roche). DIG RNA pull-down experi-
ments were performed following a modification of a previously de-
scribed procedure (Hsu et al., 2009). Briefly, cell extracts (2.5 × 107 
H2-b2T neuroepithelial cells/ml) were prepared in extraction buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Triton X-100, 15 mg/
ml tRNA, 1× protease inhibitor [Roche], 1000 U/ml Protector RNase 
inhibitor [Roche]), and then precleared with preequilibrated Protein 
G Sepharose 4 Fast Flow beads (GE Healthcare). DIG RNA (10 μm) 
was mixed with 400 μl of extract and incubated on a rotator for 1 h 
at 4°C. Anti-digoxigenin was added (1:500 [vol:vol] dilution) to 
each binding reaction, and the mixture was further incubated on a 
rotator overnight at 4°C. Preequilibrated Protein G Sepharose 4 Fast 
Flow beads (20 μl) were then added to each binding reaction, and 
the mixture was incubated for 90 min at 4°C. Beads were then iso-
lated by centrifugation, washed five times with extraction buffer, 
and boiled in SDS sample buffer. In parallel, aliquots of the cell ex-
tract (INPUT) were ten times concentrated using Ultracel-3K centrif-
ugal filter units (Millipore), and boiled in SDS sample buffer. Immu-
noprecipitates and inputs were resolved on a 12% SDS-protein 
gel and subjected to immunoblot analysis using an anti-Elavl1/
HuR–specific antibody.
Electroporation
In ovo electroporation was performed following standard proce-
dures. Plasmids (1 μg/μl) were injected into the brain ventricle of 
stage HH12 chick embryos (Hamburger and Hamilton, 1951). Elec-
troporation was then performed with a TSS20 OVODYNE electropo-
rator (Intracel, Royston, UK), programmed to deliver five 50-ms, 
12-V pulses at a 300-ms frequency. The eggs were sealed and 
allowed to develop for another 4 h. At this point, embryos were 
removed and fixed for 3 h at room temperature with 4% paraform-
aldehyde (PFA).
Explant electroporation was performed as previously described 
(Morillo et al., 2010). E12 mouse brains were dissected in the pres-
ence of 2.4 U/ml dispase (Invitrogen) to facilitate the removal of the 
mesenchyme. The tissue was fragmented into small pieces of ap-
proximately 10 mm2, which were laid onto glass coverslips (Menzel-
Gläser, Braunschweig, Germany) and immersed in 4 μl of PBS con-
taining (i) 250 ng/μl pSilencer 1.0-U6 plus 250 ng/μl pRFPRNAiC, 
(ii) 250 ng/μl pSilencer-Elavl1/1 plus 250 ng/μl pRFPRNAiC, 
(iii) 250 ng/μl pSilencer 1.0-U6 plus 125 ng/μl pRFPRNAiC and 125 
ng/μl pCEP4-Dll1, or (iv) 250 ng/μl pSilencer-Elavl1/1 plus 125 ng/μl 
pRFPRNAiC and 125 ng/μl pCEP4-Dll1. Electroporation was per-
formed with a TSS20 OVODYNE electroporator using four 50-ms 
pulses of 25 V, at a 500-ms frequency. After electroporation, the 
explants were grown in suspension for 4 h in DMEM/F12 medium 
(Sigma) containing N2 supplement (DMEM/F12/N2; Invitrogen). 
Explants were then dissociated as previously described (Frade and 
Rodríguez-Tébar, 2000) and cultured for 18 h as described later in 
the text.
Cell culture
H2-b2T immortalized neuroepithelial cells (Nardelli et al., 2003) 
were maintained at 37ºC in RPMI 1640 medium containing Gluta-
MAX I, 25 mM HEPES (Invitrogen), 10% fetal calf serum (Invitrogen), 
and streptomycin/penicillin (Invitrogen). Cultures were synchronized 
in S-phase for 24 h with 10 mM HU (Sigma), or in M for 24 h with 1 
μg/ml colchicine (Sigma). In some cases, BrdU (0.5 μg/ml) was added 
to label cells in S-phase, whereas in other cases, transcription was 
blocked by adding 5 μg/ml actinomycin D (Sigma). Transfection of 
H2-b2T neuroepithelial cells (40,000–45,000 cells/cm2) was per-
formed with Lipofectin 2000 (Invitrogen). Polyclonal cell lines consti-
tutively expressing EGFP were generated after transfection of 
pEGFP-N1, pEGFP-Notch1–3′UTR, or pEGFP-Dll1–3′UTR, followed 
by selection with 1.5 mg/ml Geneticin-418 (G-418; Invitrogen) dur-
ing the first 5 d, and then they were maintained with 3 mg/ml G-418. 
Parental cells were observed to die by 3 d after 1.5 mg/ml G-418 
treatment. Dissociated precursor cells from E12 mouse brain were 
cultured at high density (200,000 cells/cm2) as previously described 
(Cisneros et al., 2008). In some instances, the brain precursors were 
cultured in the presence of 1 μg/ml colchicine for 20 h and then 
used for RNP-IP.
RNAi
H2-b2T neuroepithelial cells, seeded at 80–90% confluence on cov-
erslips previously coated with 20 μg/ml poly-l-lysine (Sigma), were 
lipofected with pRFPRNAiC (expressing RFP) plus pSilencer interfer-
ence or pSilencer control plasmids, and synchronized with 1 μg/ml 
colchicine (Sigma) for 24 h. Similar results were obtained with both 
pairs of RNAi constructs.
Immunocytochemistry
H2-b2T cells or E12 brain precursors cultured as described earlier in 
the text were fixed with 4% PFA for 15 min, and then permeabilized 
for 30 min at room temperature with 0.5% Triton X-100 in PBS (PBT). 
Immunolabeling was performed as previously described (Cisneros 
et al., 2008). For BrdU immunolabeling, cultures were previously 
subjected to DNA denaturation by incubation for 30 min with 2N 
HCl/0.33× PBS at room temperature, followed by a neutralization 
step consisting of three 15-min washes with 0.1 M sodium borate, 
pH 8.9, and two washes of 5 min each with PBT. Nuclei were coun-
terstained with 1 μg/ml bisbenzimide. Images were recorded using 
a DXM 1200 digital camera (Nikon, Melville, NY), and they were 
processed only minimally using Adobe Photoshop (version 11.0). 
Color balance was applied to all parts of the image, as well as to the 
controls, equally.
Immunohistochemistry
Cryosections (15 μm) were washed with PBS and permeabilized for 
30 min at room temperature in the presence of PBT. Immunostaining 
was performed as previously described (Murciano et al., 2002). Nu-
clei were counterstained with 1 μg/ml bisbenzimide. Images were 
recorded using confocal microscopy (Leica TCS-SP5; Leica, Wetzlar, 
Germany), and they were processed as described earlier in the text.
Western blot
Cell extracts were separated by SDS–PAGE on 11% acrylamide gels 
under reducing conditions and transferred to Immun-Blot polyvi-
nylidene difluoride membranes (Bio-Rad, Hercules, CA). Membranes 
were blocked for 2 h with 2% ECL Advance blocking agent (ECL 
Advance Western Blotting Detection Kit; GE Healthcare) in PBS with 
0.1% Tween 20 (PBTW), and then incubated successively with the 
appropriate antibodies. After washing with PBTW several times, 
membranes were incubated with peroxidase-coupled secondary 
antibodies and washed several times again, then finally specific sig-
nal was revealed with ECL Advance reagent.
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